Commissioner of the Food and Drug Administration Dr. Scott Gottlieb and director of the National Cancer Institute Dr. Norman E. “Ned” Sharpless, discuss the latest advances and challenges in the field of oncology, including precision medicine, immunotherapy and other innovative drugs.
More info
FDA Commissioner, Legislators Join Imagine An Answer for a Night of Renewed Commitment to Finding a Cure to Childhood Cancer Leaders from across the policy-making arena expressed their bi- partisan commitment to find a cure for pediatric brain cancer at a special presentation and reception...
More info
For many people, September is back-to-school month, and back-to-work month for those lucky vacationers. But for families with a child with cancer, there is no vacation from the grind of doctors, treatments, and sickness.
More info
Targeted therapies and immunotherapy are in a phase of discovery that is more promising than any past brain cancer research, according to the leaders of Dana-Farber’s Center for Neuro-Oncology.
More info
Eat more fruits and vegetables, don’t put plastic containers in the microwave or dishwasher and check recycling codes to reduce exposure to chemicals.
More info
Momcology is excited to announce participation as a non-profit organizer for the September 13, 2018 Patient Focused Drug Development Workshop regarding chemotherapy induced hearing loss in the pediatric cancer patient population.
More info
Many forms of childhood cancers have gone from being a death sentence to a curable disease. Thanks to advances in treatments, the overall survival rate for childhood cancers has increased from 10% a few decades ago to nearly 90% today. This means that by the year 2020, an estimated half a...
More info
Every month symbolizes a cause these days, and May is Brain Tumor Awareness month. Having a son with a brain tumor of course makes my perspective invalid. However, my friends have their own sad stories of loved ones lost to brain tumors, and the news is full of stories of brain tumor victims...
More info
Children with brain tumors that have failed to respond to treatment, or that have returned, will be able to enroll in a Phase 1 clinical trial evaluating an immunotherapy that Apexigen developed. The trial, a collaboration between Apexigen and the Pediatric Brain Tumor Consortium, will evaluate...
More info
Clay came home from National Rehabilitation Hospital in March. He was meeting all their goals for mobility and physical therapy, but still not thriving. They (and we) feared that if he stayed there any longer he would never want to leave…
More info
Clay hams it up with one of the chaplain’s who played D.J. for a trivia game at Children’s Hospital. It is a good sign that Clay called into the hotline, and won a prize or two for identifying the correct song. He is now settled into “rehab” on the same campus as...
More info